[Transcatheter devices for chronic heart failure: state of the art]
2022-01-01 Pancaldi, Edoardo; Benenati, Stefano; Emdin, Michele; Pastormelo, Luigi Emilio; Porto, Italo; Sinagra, Gianfranco; Stolfo, Davide; Tomasoni, Daniela; Metra, Marco; Adamo, Marianna
What will be the impact of sacubitril/valsartan in clinical practice?
2018-01-01 Metra, Marco
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation
2012-01-01 Metra, Marco; L., Bettari; F., Pagani; Lazzarini, Valentina; Lombardi, Carlo Mario; Carubelli, Valentina; G., Bonetti; S., Bugatti; G., Parrinello; Caimi, Luigi; G. M., Felker; Dei Cas, Livio
Role ofaliskiren on arterial stiffness and endothelial function in patients with primary hypertension
2014-01-01 Bonadei, Ivano; Vizzardi, Enrico; D'Aloia, A; Sciatti, E; Raddino, Riccardo; Metra, Marco
Evaluation of Lower Dental Arch Crowding and Dimension after Treatment with Lip Bumper versus Schwarz Appliance. A Prospective Pilot Study
2020-01-01 Quinzi, V; Caruso, S; Mummolo, S; Nota, A; Angelone, Am; Mattei, A; Gatto, R; Marzo, G.
Costo-beneficio del paziente con scompenso cronico
1997-01-01 Metra, Marco; Nodari, Savina; Daloia, A; Zanini, R; Dei Cas, Livio
Ejection fraction in heart failure: just become Emperor's new clothes?
2022-01-01 Pagnesi, Matteo; Butler, Javed; Metra, Marco
A rationale for the use of BETA-blockers as standard treatment for heart failure
2000-01-01 Metra, Marco; Nodari, Savina; Daloia, A; Bontempi, L; Boldi, E; Dei Cas, Livio
Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum
2021-01-01 Bistola, Vasiliki; Simitsis, Panagiotis; Parissis, John; Ouwerkerk, Wouter; Van Veldhuisen, Dirk J; Cleland, John G; Anker, Stefan D; Samani, Nilesh J; Metra, Marco; Zannad, Faiez; Polyzogopoulou, Eftihia; Keramida, Kalliopi; Farmakis, Dimitrios; Voors, Adriaan A; Filippatos, Gerasimos
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes
2013-01-01 Metra, Marco; Cotter, G.; Davison, B. A.; Felker, G. M.; Filippatos, G.; Greenberg, B. H.; Ponikowski, P.; Unemori, E.; Voors, A. A.; Adams, K. F.; Dorobantu, M. I.; Grinfeld, L.; Jondeau, G.; Marmor, A.; Masip, J.; Pang, P. S.; Werdan, K.; Prescott, M. F.; Edwards, C.; Teichman, S. L; Trapani, A.; Bush, C. A.; Saini, R.; Schumacher, C.; Severin, T.; Teerlink, J. R.
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure
2007-01-01 Remme, Wj; Cleland, Jg; Erhardt, L; Spark, P; Torp Pedersen, C; Metra, Marco; Komajda, M; Moullet, C; Lukas, Ma; Poole Wilson, P; Di Lenarda, A; Swedberg, K.
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure
2014-01-01 Lombardi, Carlo Mario; Carubelli, V; Lazzarini, V; Vizzardi, Enrico; Quinzani, F; Guidetti, F; Rovetta, R; Nodari, Savina; Gheorghiade, M; Metra, Marco
January 2022 at a glance: time for the new ESC guidelines on heart failure
2022-01-01 Tomasoni, Daniela; Adamo, Marianna; Metra, Marco
L’ivabradina: un nuovo farmaco per il trattamento della cardiopatia ischemica e dell’insufficienza cardiaca
2011-01-01 Metra, Marco; Dei Cas, Livio
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis
2020-01-01 Nunez, J.; Bayes-Genis, A.; Revuelta-Lopez, E.; Ter Maaten, J. M.; Minana, G.; Barallat, J.; Cserkoova, A.; Bodi, V.; Fernandez-Cisnal, A.; Nunez, E.; Sanchis, J.; Lang, C.; Ng, L. L.; Metra, M.; Voors, A. A.
Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials
2022-01-01 Grand, Johannes; Miger, Kristina; Sajadieh, Ahmad; Køber, Lars; Torp-Pedersen, Christian; Ertl, Georg; López-Sendón, José; Pietro Maggioni, Aldo; Teerlink, John R; Sato, Naoki; Gimpelewicz, Claudio; Metra, Marco; Holbro, Thomas; Nielsen, Olav W
Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure
1992-01-01 Metra, Marco; Cannella, G; La Canna, G; Guaini, T; Sandrini, M; Gaggiotti, M; Movilli, E; Dei Cas, Livio
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
2009-01-01 Khan, H; Metra, Marco; Blair, Je; Vogel, M; Harinstein, Me; Filippatos, Gs; Sabbah, Hn; Porchet, H; Valentini, G; Gheorghiade, M.
Journal Cardiovascular Medicine: welcome to our increase in ranking!
2022-01-01 Metra, Marco
Medical misinformation: Vet the message!
2019-01-01 Hill, Joseph A; Agewall, Stefan; Baranchuk, Adrian; Booz, George W; Borer, Jeffrey S; Camici, Paolo G; Chen, Peng-Sheng; Dominiczak, Anna F; Erol, Çetin; Grines, Cindy L; Gropler, Robert; Guzik, Tomasz J; Heinemann, Markus K; Iskandrian, Ami E; Knight, Bradley P; London, Barry; Lüscher, Thomas F; Metra, Marco; Musunuru, Kiran; Nallamothu, Brahmajee K; Natale, Andrea; Saksena, Sanjeev; Picard, Michael H; Rao, Sunil V; Remme, Willem J; Rosenson, Robert S; Sweitzer, Nancy K; Timmis, Adam; Vrints, Christiaan
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Transcatheter devices for chronic heart failure: state of the art] | 1-gen-2022 | Pancaldi, Edoardo; Benenati, Stefano; Emdin, Michele; Pastormelo, Luigi Emilio; Porto, Italo; Sinagra, Gianfranco; Stolfo, Davide; Tomasoni, Daniela; Metra, Marco; Adamo, Marianna | |
| What will be the impact of sacubitril/valsartan in clinical practice? | 1-gen-2018 | Metra, Marco | |
| Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation | 1-gen-2012 | Metra, Marco; L., Bettari; F., Pagani; Lazzarini, Valentina; Lombardi, Carlo Mario; Carubelli, Valentina; G., Bonetti; S., Bugatti; G., Parrinello; Caimi, Luigi; G. M., Felker; Dei Cas, Livio | |
| Role ofaliskiren on arterial stiffness and endothelial function in patients with primary hypertension | 1-gen-2014 | Bonadei, Ivano; Vizzardi, Enrico; D'Aloia, A; Sciatti, E; Raddino, Riccardo; Metra, Marco | |
| Evaluation of Lower Dental Arch Crowding and Dimension after Treatment with Lip Bumper versus Schwarz Appliance. A Prospective Pilot Study | 1-gen-2020 | Quinzi, V; Caruso, S; Mummolo, S; Nota, A; Angelone, Am; Mattei, A; Gatto, R; Marzo, G. | |
| Costo-beneficio del paziente con scompenso cronico | 1-gen-1997 | Metra, Marco; Nodari, Savina; Daloia, A; Zanini, R; Dei Cas, Livio | |
| Ejection fraction in heart failure: just become Emperor's new clothes? | 1-gen-2022 | Pagnesi, Matteo; Butler, Javed; Metra, Marco | |
| A rationale for the use of BETA-blockers as standard treatment for heart failure | 1-gen-2000 | Metra, Marco; Nodari, Savina; Daloia, A; Bontempi, L; Boldi, E; Dei Cas, Livio | |
| Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum | 1-gen-2021 | Bistola, Vasiliki; Simitsis, Panagiotis; Parissis, John; Ouwerkerk, Wouter; Van Veldhuisen, Dirk J; Cleland, John G; Anker, Stefan D; Samani, Nilesh J; Metra, Marco; Zannad, Faiez; Polyzogopoulou, Eftihia; Keramida, Kalliopi; Farmakis, Dimitrios; Voors, Adriaan A; Filippatos, Gerasimos | |
| Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes | 1-gen-2013 | Metra, Marco; Cotter, G.; Davison, B. A.; Felker, G. M.; Filippatos, G.; Greenberg, B. H.; Ponikowski, P.; Unemori, E.; Voors, A. A.; Adams, K. F.; Dorobantu, M. I.; Grinfeld, L.; Jondeau, G.; Marmor, A.; Masip, J.; Pang, P. S.; Werdan, K.; Prescott, M. F.; Edwards, C.; Teichman, S. L; Trapani, A.; Bush, C. A.; Saini, R.; Schumacher, C.; Severin, T.; Teerlink, J. R. | |
| Effect of carvedilol and metoprolol on the mode of death in patients with heart failure | 1-gen-2007 | Remme, Wj; Cleland, Jg; Erhardt, L; Spark, P; Torp Pedersen, C; Metra, Marco; Komajda, M; Moullet, C; Lukas, Ma; Poole Wilson, P; Di Lenarda, A; Swedberg, K. | |
| Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure | 1-gen-2014 | Lombardi, Carlo Mario; Carubelli, V; Lazzarini, V; Vizzardi, Enrico; Quinzani, F; Guidetti, F; Rovetta, R; Nodari, Savina; Gheorghiade, M; Metra, Marco | |
| January 2022 at a glance: time for the new ESC guidelines on heart failure | 1-gen-2022 | Tomasoni, Daniela; Adamo, Marianna; Metra, Marco | |
| L’ivabradina: un nuovo farmaco per il trattamento della cardiopatia ischemica e dell’insufficienza cardiaca | 1-gen-2011 | Metra, Marco; Dei Cas, Livio | |
| Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis | 1-gen-2020 | Nunez, J.; Bayes-Genis, A.; Revuelta-Lopez, E.; Ter Maaten, J. M.; Minana, G.; Barallat, J.; Cserkoova, A.; Bodi, V.; Fernandez-Cisnal, A.; Nunez, E.; Sanchis, J.; Lang, C.; Ng, L. L.; Metra, M.; Voors, A. A. | |
| Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials | 1-gen-2022 | Grand, Johannes; Miger, Kristina; Sajadieh, Ahmad; Køber, Lars; Torp-Pedersen, Christian; Ertl, Georg; López-Sendón, José; Pietro Maggioni, Aldo; Teerlink, John R; Sato, Naoki; Gimpelewicz, Claudio; Metra, Marco; Holbro, Thomas; Nielsen, Olav W | |
| Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure | 1-gen-1992 | Metra, Marco; Cannella, G; La Canna, G; Guaini, T; Sandrini, M; Gaggiotti, M; Movilli, E; Dei Cas, Livio | |
| Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? | 1-gen-2009 | Khan, H; Metra, Marco; Blair, Je; Vogel, M; Harinstein, Me; Filippatos, Gs; Sabbah, Hn; Porchet, H; Valentini, G; Gheorghiade, M. | |
| Journal Cardiovascular Medicine: welcome to our increase in ranking! | 1-gen-2022 | Metra, Marco | |
| Medical misinformation: Vet the message! | 1-gen-2019 | Hill, Joseph A; Agewall, Stefan; Baranchuk, Adrian; Booz, George W; Borer, Jeffrey S; Camici, Paolo G; Chen, Peng-Sheng; Dominiczak, Anna F; Erol, Çetin; Grines, Cindy L; Gropler, Robert; Guzik, Tomasz J; Heinemann, Markus K; Iskandrian, Ami E; Knight, Bradley P; London, Barry; Lüscher, Thomas F; Metra, Marco; Musunuru, Kiran; Nallamothu, Brahmajee K; Natale, Andrea; Saksena, Sanjeev; Picard, Michael H; Rao, Sunil V; Remme, Willem J; Rosenson, Robert S; Sweitzer, Nancy K; Timmis, Adam; Vrints, Christiaan |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista38872
Data di pubblicazione
- In corso di stampa10
- 2020 - 202711055
- 2010 - 201915888
- 2000 - 20097439
- 1990 - 19993473
- 1980 - 1989929
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.770
- Elsevier B.V.747
- John Wiley and Sons Inc493
- Springer Science and Business Med...489
- Oxford University Press456
- Lippincott Williams and Wilkins405
- Springer349
- MDPI348
- Elsevier Ltd319
- Springer Nature254
Rivista
- EUROPEAN UROLOGY527
- BLOOD372
- PLOS ONE309
- EUROPEAN JOURNAL OF HEART FAILURE273
- JOURNAL OF NEUROLOGY273
- NEUROLOGY267
- DIGESTIVE AND LIVER DISEASE246
- EUROPEAN HEART JOURNAL222
- MULTIPLE SCLEROSIS212
- SCIENTIFIC REPORTS209
Keyword
- Humans3554
- Male2081
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- Retrospective Studies628
- COVID-19624
- Treatment Outcome603
- Prognosis475
Lingua
- eng28289
- ita1929
- fre64
- und55
- spa34
- ger25
- por12
- rus6
- grc3
- pol3
Accesso al fulltext
- no fulltext33686
- open3003
- reserved2089
- partially open82
- embargoed11
- mixed1